Fig. 1.
Overall survival since the initiation of treatment (n = 96): The 2-year OS was 40.6 %, with a median follow-up of 26 months (range, 11–56 months), and the estimated overall survival time was 21.0 months
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.